Kinaxis Inc.
TSX:KXS.TOSoftware - Application
-$2.74 today
- Market cap
- $6.15B
- Beta
- 0.78
- P/E (TTM)
- 35.0
- EPS (TTM)
- $3.02
Volume 0.14M
Average 0.12M
KXS.TO Inventory
Cash effect of the change in inventory; building inventory consumes cash.
Kinaxis Inc.TSX: KXS.TO
Inventory · Q2 FY2026 · quarter ended Jun 2026
Inventory outflow grows to $0
Q2 FY2026 inventory was $0, compared with $0 a year earlier. Trailing-twelve-month inventory was $0.
Context
- Inventory amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Inventory increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly inventory holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Cash FlowText generated from reported figures; not investment advice.
Inventory history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Inventory | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Inventory vs competitors
How KXS.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so inventory is compared through growth and share of revenue rather than absolute size.
- Inventory amounts to 0.0% of revenue for KXS.TO, versus a peer median of 1.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jan 2026 | CA$4.51M CAD | +227.2% | +169.9% | 2.4% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jul 2026 | $0 USD | +100.0% | — | 0.0% | |
| Peer median (excluding KXS.TO) | — | +163.6% | +169.9% | 1.2% | |
Competitors are the stored peer set for KXS.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (1.15M) | 19.48M | 10.22M | 53.31K | 71.94M |
| Depreciation & Amortization | 27.07M | 32.85M | 35.82M | 24.93M | 33.22M |
| Deferred Income Tax | 0 | 0 | 0 | (10.46M) | (8.23M) |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 5.43M | (47.66M) | 5.46M | 856.79K | 3.54M |
| Accounts Receivables | (6.67M) | (72.89M) | 6.66M | 140.89K | (4.64M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 8.64M | 1.63M | (2.62M) | 4.49M | (8.12M) |
| Other Working Capital | 3.46M | 23.6M | 1.42M | (3.78M) | 16.3M |
| Other Non-Cash Items | 17.94M | 19.12M | 29.15M | 79.07M | 19.4M |
| Operating Cash Flow | 49.3M | 23.79M | 80.64M | 94.45M | 119.86M |
| Capital Expenditures | (33.26M) | (17.71M) | (2.34M) | (4.3M) | (5.79M) |
| Acquisitions (Net) | (786.57K) | (35.64M) | 0 | 0 | 0 |
| Purchases of Investments | (70.4M) | (77.92M) | (209.01M) | (325.65M) | (629.93M) |
| Sales of Investments | 70.4M | 58.52M | 142.95M | 316.98M | 579.66M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (34.05M) | (72.76M) | (68.4M) | (12.97M) | (56.06M) |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 10.58M | 28.83M | 32.07M | 20.52M | 20.71M |
| Common Stock Repurchased | 0 | 0 | (37.21M) | (93.56M) | (98.73M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (4.83M) | (2.79M) | (7.09M) | (6.63M) | (5.94M) |
| Financing Cash Flow | 5.75M | 26.04M | (12.23M) | (79.67M) | (83.96M) |
| Effect of Forex Changes | (2.48M) | 8.68M | (5.31M) | 10.07M | (10.84M) |
| Net Change in Cash | 18.51M | (14.24M) | (5.3M) | 11.88M | (30.99M) |
| Free Cash Flow | 16.03M | 6.08M | 78.31M | 90.15M | 114.07M |
Kinaxis Inc.
TSX:KXS.TO
Intrinsic Alpha fair value
Locked
Current Price
$227.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.